TITLE

thalidomide

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p2167
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "thalidomide," is presented. It means a drug which was removed from the market as it caused severe birth defects like malformations of the limbs of exposed fetuses. The drug is extremely useful for the treatment of erythema nodosum leprosum, multiple myeloma, Kaposi's sarcoma, and immunological diseases.
ACCESSION #
21248336

 

Related Articles

  • myelomatosis.  // Taber's Cyclopedic Medical Dictionary;2005, p1414 

    A definition of the medical term "myelomatosis" is presented, which is an old term for multiple myeloma. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co.

  • plasmocyte.  // Taber's Cyclopedic Medical Dictionary;2005, p1684 

    A definition of the medical term "plasmocyte" is presented. It refers to the malignant cells found in the bone marrow and occasionally in the blood of persons with multiple myeloma. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co.

  • 11. Role of novel therapies targeting the myeloma cells and its marrow microenvironment.  // Hematology Journal;2003 Supplement, Vol. 4 Issue 1, pS226 

    The Hematology Journal (2003) 4, S226-S267. doi:10.1038/sj.thj.6200291

  • Thalidomide.  // Reactions Weekly;3/15/2008, Issue 1193, p27 

    The article presents case reports of nine patients who developed arterial and venous thrombotic complications after receiving thalidomide for multiple myeloma. The patient characteristics are described including their sex, age, thrombosis onset and lesion type. All of them received oral...

  • Thalidomide.  // Reactions Weekly;3/14/2009, Issue 1243, p42 

    The article presents two case studies of women with multiple myeloma who developed hepatotoxicity while receiving thalidomide. The first patient started receiving 28-day cycles of thalidomide 50 mg/day and pulse dexamethasone with weekly thalidomide dosage increases of 50 mg/day to a maximum of...

  • Thalidomide.  // Reactions Weekly;4/11/2009, Issue 1247/1248, p33 

    The article describes the case of a 71-year-old man who developed pneumonitis following the administration of thalidomide for multiple myeloma. The patient became febrile 12 days after receiving thalidomide. Thalidomide and other antibacterial therapy were stopped and the patient's symptoms...

  • New therapies in multiple myeloma. Merchionne, F.; Perosa, F.; Dammacco, F. // Clinical & Experimental Medicine;Sep2007, Vol. 7 Issue 3, p83 

    The melphalan-prednisone regimen has been considered as standard therapy for patients with multiple myeloma (MM) for many years. Recently, high-dose chemotherapy with stem-cell support has extended progression-free survival and increased overall survival, and it is now considered conventional...

  • Population pharmacokinetics of lenalidomide in multiple myeloma patients. Guglieri-López, Beatriz; Pérez-Pitarch, Alejandro; Moes, Dirk; Porta-Oltra, Begoña; Climente-Martí, Mónica; Guchelaar, Henk; Merino-Sanjuán, Matilde; Guglieri-López, Beatriz; Pérez-Pitarch, Alejandro; Moes, Dirk Jan A R; Porta-Oltra, Begoña; Climente-Martí, Mónica; Guchelaar, Henk Jan; Merino-Sanjuán, Matilde // Cancer Chemotherapy & Pharmacology;Jan2017, Vol. 79 Issue 1, p189 

    Purpose: Lenalidomide disease-specific toxicity profiles and potentially life-threatening adverse events support the consideration of diversity in starting doses. The aim of this study was to conduct a population pharmacokinetic analysis of lenalidomide in multiple myeloma patients...

  • PIPELINE PREVIEW.  // Managed Healthcare Executive;Dec2004, Vol. 14 Issue 12, p58 

    The article focuses on pipeline preview of various drugs. Drospirenone/estradiol is approved for hormone replacement therapy. Thalidomide is approved for the treatment of multiple myeloma. Modified Vaccinia Ankara vaccine is for use in individuals in whom the traditional smallpox vaccine is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics